Back to search
Inclusion Body Myositis (IBM)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Inclusion Body Myositis (IBM) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Inclusion Body Myositis (IBM) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their cause and the immune system changes and medical problems as…
Refer to the "Detailed Description" section.
This single-arm pilot study evaluates the effects of whole-body electrical muscle stimulation (WB-EMS) exercise on neuromuscular and physical function in adults…
Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not…
To evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in patients with sIBM
Inclusion-Body Myositis (IBM) results in weakness and the deterioration of distal arm muscles, the symptoms of which are currently assessed through expert exami…
Background: * Myositis is a rare disease in which the body s immune cells attack the muscle tissue. It can cause muscle weakness, swelling, and pain. It can de…